Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,383
  • Shares Outstanding, K 17,480
  • Annual Sales, $ 7,190 K
  • Annual Income, $ -50,080 K
  • EBIT $ -45 M
  • EBITDA $ -44 M
  • 60-Month Beta 0.38
  • Price/Sales 1.41
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.77
  • Most Recent Earnings $-0.66 on 07/29/24
  • Next Earnings Date 11/14/24 [AMC]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 102.06%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 11/08/24
  • IV Low 0.00% on 11/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 9,197
  • Open Int (30-Day) 8,910

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5082 +3.11%
on 11/12/24
1.8600 -71.83%
on 10/23/24
-0.9560 (-64.59%)
since 10/11/24
3-Month
0.5082 +3.11%
on 11/12/24
4.0400 -87.03%
on 08/19/24
-3.2160 (-85.99%)
since 08/12/24
52-Week
0.5082 +3.11%
on 11/12/24
8.3799 -93.75%
on 12/28/23
-4.1960 (-88.90%)
since 11/10/23

Most Recent Stories

More News
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

TTOO : 0.5240 (-11.78%)
What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

XLV : 147.22 (-1.39%)
$SPX : 5,983.99 (-0.29%)
TTOO : 0.5240 (-11.78%)
CAH : 123.51 (+1.54%)
T2 Biosystems to Host Business Update Call on October 10, 2024

TTOO : 0.5240 (-11.78%)
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

TTOO : 0.5240 (-11.78%)
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

TTOO : 0.5240 (-11.78%)
CAH : 123.51 (+1.54%)
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results

TTOO : 0.5240 (-11.78%)
T2 Biosystems: Q2 Earnings Snapshot

T2 Biosystems: Q2 Earnings Snapshot

TTOO : 0.5240 (-11.78%)
T2 Biosystems: Q1 Earnings Snapshot

T2 Biosystems: Q1 Earnings Snapshot

TTOO : 0.5240 (-11.78%)
T2 Biosystems: Q3 Earnings Snapshot

T2 Biosystems: Q3 Earnings Snapshot

TTOO : 0.5240 (-11.78%)
Why Shares of T2 Biosystems Are Falling Friday

A revenue drop and a reverse stock split worried investors.

TTOO : 0.5240 (-11.78%)

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

3rd Resistance Point 0.6587
2nd Resistance Point 0.6255
1st Resistance Point 0.5747
Last Price 0.5240
1st Support Level 0.4907
2nd Support Level 0.4575
3rd Support Level 0.4067

See More

52-Week High 8.3799
Fibonacci 61.8% 5.3729
Fibonacci 50% 4.4440
Fibonacci 38.2% 3.5152
Last Price 0.5240
52-Week Low 0.5082

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar